Apollo Endosurgery Analysis
Apollo Endosurgery is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Apollo Endosurgery delisted stock analysis is to determine its intrinsic value, which is an estimate of what Apollo Endosurgery is worth, separate from its market price. There are two main types of Apollo Endosurgery's stock analysis: fundamental analysis and technical analysis.
The Apollo Endosurgery stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Apollo Endosurgery is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Apollo Stock trading window is adjusted to America/New York timezone.
Apollo |
Apollo Stock Analysis Notes
About 63.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.06. Apollo Endosurgery last dividend was issued on the 30th of December 2016. The entity had 1:5 split on the 30th of December 2016. Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas. Apollo Endosurgery operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 202 people. For more info on Apollo Endosurgery please contact Charles McKhann at 512 279-5100 or go to www.apolloendo.com.Apollo Endosurgery Investment Alerts
| Apollo Endosurgery is not yet fully synchronised with the market data | |
| Apollo Endosurgery has some characteristics of a very speculative penny stock | |
| Apollo Endosurgery has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 76.86 M. Net Loss for the year was (39.84 M) with profit before overhead, payroll, taxes, and interest of 42.43 M. | |
| Apollo Endosurgery currently holds about 74.74 M in cash with (31.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.84. | |
| Roughly 63.0% of the company shares are held by institutions such as insurance companies |
Apollo Endosurgery Upcoming and Recent Events
Earnings reports are used by Apollo Endosurgery to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 28th of March 2023 Upcoming Quarterly Report | View | |
| 2nd of May 2023 Next Financial Report | View | |
| 31st of December 2022 Next Fiscal Quarter End | View | |
| 28th of March 2023 Next Fiscal Year End | View | |
| 30th of September 2022 Last Quarter Report | View | |
| 31st of December 2021 Last Financial Announcement | View |
Apollo Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 579.72 M.Apollo Profitablity
The company has Profit Margin (PM) of (0.52) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.36) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.36.Apollo Endosurgery Outstanding Bonds
Apollo Endosurgery issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Apollo Endosurgery uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Apollo bonds can be classified according to their maturity, which is the date when Apollo Endosurgery has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US03765HAB78 Corp BondUS03765HAB78 | View | |
| US03765HAD35 Corp BondUS03765HAD35 | View | |
| US03765HAF82 Corp BondUS03765HAF82 | View | |
| US03762UAD72 Corp BondUS03762UAD72 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Apollo Endosurgery to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Apollo Stock
If you are still planning to invest in Apollo Endosurgery check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apollo Endosurgery's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |